Results 1 to 10 of about 20 (20)

Antibiotic resistance in the patient with cancer: Escalating challenges and paths forward

Ca-A Cancer Journal for Clinicians, 2021
Amila K Nanayakkara, David E Greenberg
exaly  

Hypoxia, Metabolic Reprogramming, and Drug Resistance in Liver Cancer

Cells, 2021
Carmen Chak-Lui Wong, Macus Hao‐Ran Bao   +1 more
exaly  

COVID-19 induces new-onset insulin resistance and lipid metabolic dysregulation via regulation of secreted metabolic factors

Signal Transduction and Targeted Therapy, 2021
Linghua Li, Tao Zuo, Li Yan
exaly  

Metabolic oncologic emergencies

Ca-A Cancer Journal for Clinicians, 1987
John H Glick, D J Glover, J H Glick
exaly  

The metabolic syndrome and uric acid nephrolithiasis: Novel features of renal manifestation of insulin resistance

Kidney International, 2004
Orson W. Moe, Nicola Abate, Khashayar Sakhaee   +2 more
exaly  

Genetics of Insulin Resistance and the Metabolic Syndrome

Current Cardiology Reports, 2016
Mark Walker
exaly  

Acetylation and insulin resistance: a focus on metabolic and mitogenic cascades of insulin signaling

Critical Reviews in Clinical Laboratory Sciences, 2020
Alireza Bahiraee, Farshad Niazpour, Solaleh Emamgholipour   +2 more
exaly  

Linking metabolic reprogramming to therapy resistance in cancer

Biochimica Et Biophysica Acta: Reviews on Cancer, 2017
Stefano Indraccolo, Andrea Morandi
exaly  

Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders

Nature, 2013
Yongxing Cao, Shaoshuai Meng, Mao Zhang
exaly  

The metabolic syndrome: Insulin resistance

Current Hypertension Reports, 2009
Nasser Mikhail
exaly